Dự phòng Huyết khối tĩnh mạch sâu/Tắc động mạch phổi ở bệnh nhân hồi sức tích cực - Nhân một trường hợp tắc động mạch phổi cấp
Tóm tắt
Dự phòng Huyết khối tĩnh mạch sâu/Tắc động mạch phổi ở bệnh nhân hồi sức tích cực - Nhân một trường hợp tắc động mạch phổi cấpTài liệu tham khảo
1. Cade JF. High risk of the critically ill for venous thromboembolism. Crit Care Med 1982;10:448–450
2. Fraisse F, Holzapfel L, Couland JM, et al; The Association of Non-University Affiliated intensive Care Specialist Physicians of France. Nadroparin in the prevention of deep vein throm- bosis in acute decompensated COPD. Am J Respir Crit Care Med 2000;161(4 Pt 1):1109–1114
3. Attia J, Ray JG, Cook dJ, douketis J, Ginsberg JS, Geerts WH. Deep vein thrombosis and its prevention in critically ill adults. Arch intern Med 2001;161:1268–1279
4. McCarthy ST, Turner JJ, Robertson d, Hawkey CJ, Macey dJ. Low-dose heparin as a prophylaxis against deep-vein thrombosis after acute stroke. Lancet 1977;2:800–801
5. Kelly J, Rudd A, Lewis R, Hunt bJ. Venous thromboemb- olism after acute stroke. Stroke 2001;32:262–267
6. McCarthy ST, Turner J. Low-dose subcutaneous heparin in the prevention of deep-vein thrombosis and pulmonary emboli following acute stroke. Age Ageing 1986;15:84–88
7. Huỳnh văn Ân, Ngô văn Thành (2009) Huyết khối tĩnh mạch sâu ở bệnh nhân nội khoa tại khoa săn sóc đặc biệt (iCU) Bệnh viện Nhân Dân Gia Định. Y học TP.HCM 13, 127-134.
8. Crowther MA, Cook dJ, Griffith LE, et al. Deep venous thrombosis: clinically silent in the intensive care unit. J Crit Care 2005;20:334–340
9. dalen JE. Pulmonary embolism: what have we learned since Virchow? Natural history, pathophysiology, and diagnosis Chest 2002;122:1440–1456
10. Chee M. Chan, Andrew F. Shorr, Venous Thromboembolic Disease in the intensive Care Unit, Seminars in respiratory and critical care medicine/ Volume 31, number 1, 2010.
11. Geerts WH, bergqvist d, Pineo GF, et al; American College of Chest Physicians. Pre- vention of venous thromboembolism: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest 2008;133(6, Suppl):381S–453S
12. Prevention of VTE in Nonsurgical Patients, Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines, CHEST 2012; 141(2)(Suppl):e195S–e226S
13. Shorr AF, Williams Md. Venous thromboembolism in crit- ically ill patients. Observa- tions from a randomized trial in sepsis. Thromb Haemost. 2009;101(1):139-144.
14. The PROTECT investigators for the Canadian Critical Care Trials Group and the Austra- lian and New Zealand intensive Care Society Clinical Trials Group. Dalteparin versus unfraction- ated heparin in critically ill patients. N Engl J Med.2011;364(14):1305-1314
15. De A, Roy P, Garg vK, Pandey NK. Low-molecular-weight heparin and unfractionated heparin in prophylaxis against deep vein thrombosis in critically ill patients undergoing major sur- gery. Blood Coagul Fibrinolysis. 2010;21(1): 57-61.
